| Biological Sciences | Lifetime | 216 | DE 13 | 99.97 |
| Medical and Health Sciences | Lifetime | 635 | DE 22 | 99.97 |
| Infectious Diseases | Lifetime | 6 | DE 1 | 99.97 |
| Immunology | Lifetime | 42 | DE 2 | 99.93 |
| Epidemiology | Lifetime | 234 | DE 12 | 99.70 |
| Molecular Biology | Lifetime | 741 | DE 45 | 99.62 |
| Biotechnology | Lifetime | 68 | DE 7 | 98.90 |
| Food Science and Technology | Lifetime | 503 | DE 22 | 98.51 |
| Endocrinology | Lifetime | 235 | DE 10 | 96.19 |
| Veterinary Science and Animal Health | Lifetime | 643 | DE 22 | 89.30 |
| Microbiology | Lifetime | 550 | DE 34 | 86.27 |
| Parasitology | Lifetime | 833 | DE 32 | 64.79 |
| Immunology | 2021-2025 | 241 | DE 19 | 94.30 |
| Infectious Diseases | 2021-2025 | 363 | DE 12 | 93.07 |
| Tuberculosis Research and Epidemiology | Lifetime | 1 | DE 1 | 99.98 |
| Mycobacterium research and diagnosis | Lifetime | 1 | DE 1 | 99.96 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 8 | DE 1 | 99.89 |
| Immune Response and Inflammation | Lifetime | 27 | DE 1 | 99.89 |
| vaccines and immunoinformatics approaches | Lifetime | 5 | DE 2 | 99.84 |
| Immune Cell Function and Interaction | Lifetime | 68 | DE 2 | 99.89 |
| Immune responses and vaccinations | Lifetime | 3 | DE 1 | 99.83 |
| Diagnosis and treatment of tuberculosis | Lifetime | 11 | DE 1 | 99.76 |
| Immunotherapy and Immune Responses | Lifetime | 74 | DE 3 | 99.86 |
| T-cell and B-cell Immunology | Lifetime | 135 | DE 4 | 99.72 |
| Heat shock proteins research | Lifetime | 35 | DE 8 | 99.21 |
| Historical Medical Research and Treatments | Lifetime | 3 | DE 1 | 99.31 |
| Listeria monocytogenes in Food Safety | Lifetime | 31 | DE 3 | 99.51 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 104 | DE 9 | 99.19 |
| Escherichia coli research studies | Lifetime | 88 | DE 8 | 99.04 |
| interferon and immune responses | Lifetime | 156 | DE 15 | 98.85 |
| Infectious Diseases and Tuberculosis | Lifetime | 130 | DE 6 | 98.65 |
| Macrophage Migration Inhibitory Factor | Lifetime | 35 | DE 4 | 98.08 |
| Ideological and Political Education | Lifetime | 22 | DE 1 | 92.77 |
| Veterinary medicine and infectious diseases | Lifetime | 63 | DE 8 | 98.34 |
| Salmonella and Campylobacter epidemiology | Lifetime | 174 | DE 9 | 98.82 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 254 | DE 8 | 98.51 |
| Immune cells in cancer | Lifetime | 355 | DE 39 | 97.97 |
| Viral gastroenteritis research and epidemiology | Lifetime | 584 | DE 24 | 98.38 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 747 | DE 32 | 97.63 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 307 | DE 21 | 97.83 |
| Antimicrobial Peptides and Activities | Lifetime | 361 | DE 33 | 97.13 |
| Bacteriophages and microbial interactions | Lifetime | 806 | DE 54 | 97.73 |
| Yersinia bacterium, plague, ectoparasites research | Lifetime | 208 | DE 22 | 96.72 |
| Leprosy Research and Treatment | Lifetime | 106 | DE 2 | 96.72 |
| Vibrio bacteria research studies | Lifetime | 446 | DE 10 | 96.97 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 622 | DE 28 | 95.87 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 930 | DE 62 | 94.77 |
| Phagocytosis and Immune Regulation | Lifetime | 752 | DE 57 | 90.92 |
| thermodynamics and calorimetric analyses | Lifetime | 624 | DE 50 | 90.12 |
| Inflammation biomarkers and pathways | Lifetime | 341 | DE 30 | 83.63 |
| German Security and Defense Policies | Lifetime | 105 | DE 73 | 63.82 |
| Tuberculosis Research and Epidemiology | 2021-2025 | 84 | DE 3 | 98.11 |
| Immune responses and vaccinations | 2021-2025 | 19 | DE 3 | 96.28 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 405 | DE 32 | 90.53 |
| Mycobacterium research and diagnosis | 2021-2025 | 507 | DE 18 | 88.17 |
